XERIS PHARMACEUTICALS, INC.
XERIS PHARMACEUTICALS, INC. is a federal contractor, registered under UEI YAV5AK7VKJ31 and CAGE code 59FN0. It has been awarded $9,163,258 in federal contracts. Primary work spans Unknown NAICS. Top awarding agencies include Department Of Health And Human Services.
Contact Information
Registration and classification details
Registration
UEI Code
YAV5AK7VKJ31CAGE Code
59FN0Entity Structure
Corporate Entity (Not Tax Exempt)Established
N/ABusiness Classifications
NAICS Codes
Federal Contracting Overview
Award totals, agency breakdown, NAICS distribution, and geographic footprint.
AI Capability Profile
Xeris Pharmaceuticals, Inc. specializes in the manufacturing of pharmaceutical preparations, with a focused expertise in the development and supply of specialty drugs, including hematological and chronic disease therapeutics. The company’s technical capabilities encompass GMP-compliant production pr...
Xeris Pharmaceuticals, Inc. specializes in the manufacturing of pharmaceutical preparations, with a focused expertise in the development and supply of specialty drugs, including hematological and chronic disease therapeutics. The company’s technical capabilities encompass GMP-compliant production processes, drug formulation optimization, and regulatory-aligned manufacturing workflows tailored to federal healthcare requirements. Their work on contracts such as the FSS award for drugs and hematology-related products and the BPA for KEVEYIS— a branded prescription medication—demonstrates proficiency in end-to-end pharmaceutical supply chain management, including product lifecycle support, inventory readiness, and compliance with federal procurement standards for controlled and specialty pharmaceuticals. The Department of Veterans Affairs is the primary federal partner, with a consistent pattern of engagement centered on the procurement of specialty pharmaceuticals for veteran care programs. This recurring relationship indicates deep alignment with VA’s clinical needs, particularly in areas requiring reliable, FDA-approved drug supply chains for conditions such as hyperkalemia and other chronic disorders. The contractor’s ability to sustain long-term agreements suggests robust quality systems, regulatory responsiveness, and operational reliability in meeting the VA’s therapeutic supply demands. Operating under NAICS 325412, Xeris Pharmaceuticals is positioned as a niche manufacturer of prescription pharmaceuticals, emphasizing specialty therapeutics over mass-market generics. Their market focus is on high-complexity, low-volume products requiring stringent control environments and specialized handling, placing them within the broader specialty pharma segment critical to federal healthcare systems. As a 2L entity headquartered in Chicago, Illinois, Xeris Pharmaceuticals operates as a mid-sized manufacturer without federal certifications such as 8(a), HUBZone, or WOSB. Their geographic footprint is centralized, with operations calibrated to support federal supply chain requirements through compliant manufacturing and distribution networks. The company’s government market positioning reflects a targeted, high-integrity supplier of specialty pharmaceuticals to mission-critical federal health agencies.
Key performance metrics
Award counts and award dollars by type, as prime and as subcontractor.
Awards Count
11
All time
Active
0
Currently performing
Completed
11
Past period of performance
Total Awards
All time
Contracts
Prime · all time
Subcontracts
Sub · all time
Grants
Prime · all time
Subgrants
Sub · all time
Award analytics
Awards by agency, industry, year, award type, size, and place of performance.
Compete with XERIS PHARMACEUTICALS, INC.
Track the contractors you bid against, and the work they win
Award history, agency mix, and NAICS coverage for XERIS PHARMACEUTICALS, INC.
AI-powered matching against your own capabilities and past performance
Teaming and subcontracting signals on every award
Automated alerts when a competitor wins in your market
Join 750+ contractors already using CLEATUS
